Chemokines stimulate human T lymphocyte transendothelial migration to utilize VLA‐4 in addition to LFA‐1

Lymphocyte infiltration in inflammation is induced by the dual actions of chemokines and cell adhesion molecules. The role of LFA‐1 and VLA‐4 in chemokine‐induced T cell transendothelial migration (TEM) across cytokine‐activated endothelium has not been examined. LFA‐1, but not VLA‐4, mediated blood T cell TEM to RANTES, macrophage inflammatory protein‐1α (MIP‐1α), and stromal cell‐derived factor‐1 (SDF‐1), and across tumor necrosis factor α (TNF‐α) or interferon‐γ (IFN‐γ) ‐stimulated endothelial cells (EC). Chemokine stimulation in combination with TNF‐α activation of EC induced TEM, which was partially mediated by VLA‐4. SDF‐1 increased a β1‐integrin activation epitope on T cells and enhanced VLA‐4‐mediated adhesion. Thus, LFA‐1 mediates TEM under most conditions, but VLA‐4 can also mediate TEM, although, in contrast to LFA‐1, this requires exogenous chemokines and EC activation. In addition, an LFA‐1‐ and VLA‐4‐independent pathway of lymphocyte TEM can also be induced by SDF‐1.

[1]  Ke Xiong,et al.  Regulation of chemokine‐induced transendothelial migration of T lymphocytes by endothelial activation: differential effects on naive and memory T cells , 2000, Journal of leukocyte biology.

[2]  Beck,et al.  Release of CXC‐chemokines by human lung microvascular endothelial cells (LMVEC) compared with macrovascular umbilical vein endothelial cells , 1999, Clinical and experimental immunology.

[3]  T. Kawai,et al.  Selective diapedesis of Th1 cells induced by endothelial cell RANTES. , 1999, Journal of immunology.

[4]  A. Whitty,et al.  Multiple Activation States of Integrin α4β1 Detected through Their Different Affinities for a Small Molecule Ligand* , 1999, The Journal of Biological Chemistry.

[5]  S. Kano,et al.  Characterization of the 4C8 Antigen Involved in Transendothelial Migration of CD26hi T Cells after Tight Adhesion to Human Umbilical Vein Endothelial Cell Monolayers , 1999, The Journal of experimental medicine.

[6]  A. Issekutz,et al.  Role of ICAM‐1 and ICAM‐2 and alternate CD11/CD18 ligands in neutrophil transendothelial migration , 1999, Journal of leukocyte biology.

[7]  M. Gunn,et al.  A high endothelial cell-derived chemokine induces rapid, efficient, and subset-selective arrest of rolling T lymphocytes on a reconstituted endothelial substrate. , 1998, Journal of immunology.

[8]  D. Patel,et al.  Fractalkine and CX3CR1 Mediate a Novel Mechanism of Leukocyte Capture, Firm Adhesion, and Activation under Physiologic Flow , 1998, The Journal of experimental medicine.

[9]  U. Deutsch,et al.  T cell interaction with ICAM‐1‐deficient endothelium in vitro: essential role for ICAM‐1 and ICAM‐2 in transendothelial migration of T cells , 1998, European journal of immunology.

[10]  J. Westwick,et al.  Chemokines: understanding their role in T-lymphocyte biology. , 1998, The Biochemical journal.

[11]  M. Baggiolini Chemokines and leukocyte traffic , 1998, Nature.

[12]  E. Butcher,et al.  Chemokines and the arrest of lymphocytes rolling under flow conditions. , 1998, Science.

[13]  P. Kubes,et al.  Differential roles of selectins and the alpha4-integrin in acute, subacute, and chronic leukocyte recruitment in vivo. , 1997, Journal of immunology.

[14]  N. Hogg,et al.  Functional relevance during lymphocyte migration and cellular localization of activated β1 integrins , 1997 .

[15]  P. Loetscher,et al.  The interleukin‐8 receptor B and CXC chemokines can mediate transendothelial migration of human skin homing T cells , 1996, European journal of immunology.

[16]  T. Springer,et al.  A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1) , 1996, The Journal of experimental medicine.

[17]  J. Sodroski,et al.  The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry , 1996, Nature.

[18]  M. Miyasaka,et al.  Treatment of established adjuvant arthritis in rats with monoclonal antibody to CD18 and very late activation antigen‐4 integrins suppresses neutrophil and T‐lymphocyte migration to the joints and improves clinical disease , 1996, Immunology.

[19]  P. Kubes,et al.  The alpha 4-integrin supports leukocyte rolling and adhesion in chronically inflamed postcapillary venules in vivo , 1996, The Journal of experimental medicine.

[20]  L. Picker,et al.  Lymphocyte Homing and Homeostasis , 1996, Science.

[21]  C. Mackay,et al.  Expression of monocyte chemoattractant protein‐1 and interleukin‐8 receptors on subsets of T cells: correlation with transendothelial chemotactic potential , 1996, European journal of immunology.

[22]  P. Brandtzaeg,et al.  Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human microvascular endothelial cells. , 1996, Journal of immunology.

[23]  T. Springer,et al.  The C–C Chemokine MCP-1 Differentially Modulates the Avidity of β1 and β2 Integrins on T Lymphocytes , 1996 .

[24]  D. Taub,et al.  Chemokines regulate T cell adherence to recombinant adhesion molecules and extracellular matrix proteins. , 1996, Journal of immunology.

[25]  T. Springer,et al.  Characterization of transendothelial chemotaxis of T lymphocytes. , 1995, Journal of immunological methods.

[26]  M. Nieto,et al.  Chemokines regulate cellular polarization and adhesion receptor redistribution during lymphocyte interaction with endothelium and extracellular matrix. Involvement of cAMP signaling pathway , 1995, The Journal of cell biology.

[27]  A. Issekutz,et al.  Domains 1 and 4 of vascular cell adhesion molecule-1 (CD106) both support very late activation antigen-4 (CD49d/CD29)-dependent monocyte transendothelial migration. , 1995, Journal of immunology.

[28]  Judith E. Cartwright,et al.  The expression and release of adhesion molecules by human endothelial cell lines and their consequent binding of lymphocytes. , 1995, Experimental cell research.

[29]  T. Springer,et al.  The integrin VLA-4 supports tethering and rolling in flow on VCAM-1 , 1995, The Journal of cell biology.

[30]  L. Picker,et al.  Migration of skin-homing T cells across cytokine-activated human endothelial cell layers involves interaction of the cutaneous lymphocyte-associated antigen (CLA), the very late antigen-4 (VLA-4), and the lymphocyte function-associated antigen-1 (LFA-1). , 1995, Journal of immunology.

[31]  T. Schall,et al.  Regulation of the production of the RANTES chemokine by endothelial cells. Synergistic induction by IFN-gamma plus TNF-alpha and inhibition by IL-4 and IL-13. , 1995, Journal of immunology.

[32]  E. Berg,et al.  α4 integrins mediate lymphocyte attachment and rolling under physiologic flow , 1995, Cell.

[33]  T. Carlos,et al.  Leukocyte-endothelial adhesion molecules. , 1994, Blood.

[34]  L. Picker Control of lymphocyte homing. , 1994, Current opinion in immunology.

[35]  L. Picker,et al.  Differential expression of lymphocyte homing receptors by human memory/effector T cells in pulmonary versus cutaneous immune effector sites , 1994, European journal of immunology.

[36]  T. Springer,et al.  Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[37]  T. Springer Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm , 1994, Cell.

[38]  T. Issekutz Dual inhibition of VLA-4 and LFA-1 maximally inhibits cutaneous delayed-type hypersensitivity-induced inflammation. , 1993, The American journal of pathology.

[39]  M. Thornhill,et al.  Leucocyte Endothelial Cell Adhesion: a Study comparing Human Umbilical Vein Endothelial Cells and the Endothelial Cell Line EA‐hy‐926 , 1993, Scandinavian journal of immunology.

[40]  D. Taub,et al.  Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells , 1993, The Journal of experimental medicine.

[41]  D. Taub,et al.  Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1 alpha and MIP-1 beta , 1993, Science.

[42]  D. Adams,et al.  T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-lβ , 1993, Nature.

[43]  A. Masumoto,et al.  Multiple activation states of VLA-4. Mechanistic differences between adhesion to CS1/fibronectin and to vascular cell adhesion molecule-1. , 1993, The Journal of biological chemistry.

[44]  N. Oppenheimer-Marks,et al.  Identification of subsets of human T cells capable of enhanced transendothelial migration. , 1992, Journal of immunology.

[45]  F. Sánchez‐Madrid,et al.  Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrin , 1992, Nature.

[46]  M. May,et al.  ICAM‐1‐independent lymphocyte transmigration across high endothelium : Differential up‐regulation by interferon γ, tumor necrosis factor‐α and interleukin 1β , 1992 .

[47]  T. Issekutz Inhibition of in vivo lymphocyte migration to inflammation and homing to lymphoid tissues by the TA-2 monoclonal antibody. A likely role for VLA-4 in vivo. , 1991, Journal of immunology.

[48]  A. Issekutz,et al.  T lymphocyte migration to arthritic joints and dermal inflammation in the rat: differing migration patterns and the involvement of VLA-4. , 1991, Clinical immunology and immunopathology.

[49]  D. T. Bogue,et al.  Differential utilization of ICAM-1 and VCAM-1 during the adhesion and transendothelial migration of human T lymphocytes. , 1991, Journal of immunology.

[50]  E. Lightfoot,et al.  Role of CD11/CD18 in adhesion and transendothelial migration of T cells. Analysis utilizing CD18-deficient T cell clones. , 1991, Journal of immunology.

[51]  D. Goeddel,et al.  Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES , 1990, Nature.

[52]  J. Pober,et al.  IFN-gamma enhances endothelial activation induced by tumor necrosis factor but not IL-1. , 1990, Journal of immunology.

[53]  C. Smith,et al.  Suppression of human lymphocyte chemotaxis and transendothelial migration by anti-LFA-1 antibody. , 1989, Journal of immunology.

[54]  N. Oppenheimer-Marks,et al.  Migration of lymphocytes through endothelial cell monolayers: augmentation by interferon-gamma. , 1988, Cellular immunology.

[55]  E. Jaffe,et al.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.

[56]  A. Whitty,et al.  Multiple activation states of integrin alpha4beta1 detected through their different affinities for a small molecule ligand. , 1999, The Journal of biological chemistry.

[57]  P. Loetscher,et al.  Lymphocyte responses to chemokines. , 1998, International reviews of immunology.

[58]  T. Springer,et al.  The C-C chemokine MCP-1 differentially modulates the avidity of beta 1 and beta 2 integrins on T lymphocytes. , 1996, Immunity.

[59]  D. Adams,et al.  Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes. , 1993, Immunology today.

[60]  D. Taub,et al.  The Effects of Human Recombinant MIP-1α, MIP-1β, and Rantes on the Chemotaxis and Adhesion of T Cell Subsets , 1993 .

[61]  D. Taub,et al.  The effects of human recombinant MIP-1 alpha, MIP-1 beta, and RANTES on the chemotaxis and adhesion of T cell subsets. , 1993, Advances in experimental medicine and biology.

[62]  D. Adams,et al.  T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta. , 1993, Nature.

[63]  Y. Tanaka,et al.  Lymphocyte interactions with endothelial cells. , 1992, Immunology today.

[64]  M. May,et al.  ICAM-1-independent lymphocyte transmigration across high endothelium: differential up-regulation by interferon gamma, tumor necrosis factor-alpha and interleukin 1 beta. , 1992, European journal of immunology.